Clinical Trials Sponsored by Vascular Scientific, LLC

Total 266 results

Janssen Scientific Affairs, LLC
Bayer

Completed

A Study of Rivaroxaban for Early Discharge of Low Risk Pulmonary Embolism From the Emergency Department (MERCURY PE)

Pulmonary Embolism

United States
Bayer
Janssen Scientific Affairs, LLC

Completed

Reduced-dosed Rivaroxaban in the Long-term Prevention of Recurrent Symptomatic VTE(Venous Thromboembolism) (EinsteinChoice)

Thrombosis | Venous Thrombosis | Thromboembolism | Venous Thromboembolism | Pulmonary Embolism

Belgium, France, China, Switzerland, New Zealand, South Africa, Hungary, United States, Canada, Australia, Netherlands, Spain, Russian Federation, Austria, Mexico, Taiwan, Brazil, Czechia, Denmark, Germany, Israel, Italy, Korea, Republic... and more
Janssen Scientific Affairs, LLC
Bayer

Completed

A Study Exploring Two Strategies of Rivaroxaban (JNJ39039039; BAY-59-7939) and One of Oral Vitamin K Antagonist in Patients With Atrial Fibrillation Who Undergo Percutaneous Coronary Intervention (PIONEER AF-PCI)

Atrial Fibrillation | Percutaneous Coronary Intervention

United States, France, Poland, Ukraine, United Kingdom, Belgium, Germany, Taiwan, Argentina, Mexico, Bulgaria, Malaysia, Romania, Russian Federation, South Africa, Turkey, Korea, Republic of, Australia, Canada, Netherlands, Denmark and more
Janssen Scientific Affairs, LLC
Bayer

Completed

A Study to Assess the Independent Effects of 4-Factor Prothrombin Complex Concentrate and Tranexamic Acid on Bleeding/Pharmacodynamics in Healthy Participants

Healthy

United States
Bayer
Janssen Scientific Affairs, LLC

Completed

Belgian Real Life Non-interventional Study (NIS) in Patients Treated With Xarelto Following an Acute Deep Vein Thrombosis (DVT) (BOX-DVT)

Venous Thrombosis

Belgium
Bayer
Janssen Scientific Affairs, LLC

Completed

Benefit-Risk Of Arterial THrombotic prEvention With Rivaroxaban for Atrial Fibrillation in France (BROTHER)

Atrial Fibrillation

France
Bayer
Janssen Scientific Affairs, LLC

Completed

Study of Rivaroxaban Use and Potential Adverse Outcomes in Routine Clinical Practice (Sweden)

Venous Thrombosis | Atrial Fibrillation | Acute Coronary Syndrome | Pulmonary Embolism

Sweden
Bayer
Janssen Scientific Affairs, LLC

Completed

Xarelto on Prevention of Stroke and Non-central Nervous System Systemic Embolism in Patients With Non-valvular Atrial Fibrillation in China: A Non-interventional Study (XASSURE)

Stroke

China
Bayer
Janssen Scientific Affairs, LLC

Completed

Use of Direct Oral Anticoagulants in UK

Stroke

United Kingdom
Janssen Scientific Affairs, LLC
Bayer

Completed

A Study Exploring Two Treatment Strategies in Patients With Atrial Fibrillation Who Undergo Catheter Ablation Therapy (VENTURE-AF)

Atrial Fibrillation

United States, France, United Kingdom, Belgium, Germany
Bayer
Janssen Scientific Affairs, LLC

Completed

Satisfaction/Quality of Life With Rivaroxaban in SPAF (Stroke Prevention in Atrial Fibrillation) Indication (SAFARI)

Atrial Fibrillation

France
Bayer
Janssen Scientific Affairs, LLC

Completed

Dose-confirmatory Bridging Study in Total Knee Replacement

Venous Thromboembolism

Japan
All4Cure
Janssen Scientific Affairs, LLC

Recruiting

Evaluating the Uptake and Utility of Clinical Pathways for Newly Diagnosed Patients With Multiple Myeloma

Multiple Myeloma | Multiple Myeloma Without Mention of Remission

United States
Bayer
Janssen Scientific Affairs, LLC

Completed

Xarelto [SPAF-QOL] Post-marketing Surveillance in Japan

Non-valvular Atrial Fibrillation (NVAF)

Japan
Janssen Scientific Affairs, LLC
Bayer

Completed

Pharmacokinetics Study of Oral Rivaroxaban in Healthy Participants

Pharmacokinetics | Healthy Participants | Bioavailability

United States
Bayer
Janssen Scientific Affairs, LLC

Completed

Belgian Real Life Non-interventional Study (NIS) on Xarelto in Non-valvular Atrial Fibrillation (AF) Patients Treated for the Prevention of Stroke and Systemic Embolism (BOX-AF)

Atrial Fibrillation

Belgium
Bayer
Janssen Scientific Affairs, LLC

Completed

Venous Thromboembolism (VTE) Treatment Study in Japanese Deep Vein Thrombosis (DVT) Patients

Deep Vein Thrombosis

Japan
Sino Medical Sciences Technology Inc.
Nova Vascular LLC

Active, not recruiting

PIONEER III Trial to Assess Safety and Efficacy of the BuMA Supreme™ Drug Coated Coronary Stent in Patients With Coronary Disease

Coronary Artery Disease

Spain, United States, Netherlands, Belgium, Switzerland, United Kingdom, Canada, Japan
Janssen Scientific Affairs, LLC
HCA Research Institute, LLC

Recruiting

A Study to Assess the Engagement and Usefulness of Care4Today Digital Platform for Disease Management in Coronary Artery Disease (CAD) and/or Peripheral Artery Disease (PAD) Population (IPACE-CVD)

Coronary Artery Disease (CAD) | Peripheral Artery Disease (PAD)

United States
Diabetes and Glandular Disease Clinic
Modern Vascular, LLC

Unknown

Exploratory Study of the Efficacy of Standard of Care Revascularization of the Lower Extremity

Diabetic Peripheral Neuropathy

United States
Augusta University
Janssen Scientific Affairs, LLC

Not yet recruiting

Pilot Study Dara-CyBorD in Newly Diagnosed Multiple Myeloma Patients With Renal Failure

Multiple Myeloma | Renal Failure

United States
Northwestern University
Janssen Scientific Affairs, LLC

Active, not recruiting

An Open-Label and Long-Term Extension Study to Evaluate the Efficacy and Safety of Ustekinumab in the Treatment of Patients With Ichthyoses

Ichthyosis

United States
LifeBridge Health
Janssen Scientific Affairs, LLC

Unknown

Synergistic Influence of Rivaroxaban on Inflammation and Coagulation Biomarkers in Patients With CAD and PAD on Aspirin Therapy

Coronary Artery Disease | Peripheral Artery Disease

United States
Ortho-McNeil Janssen Scientific Affairs, LLC

Completed

Lab School Day Study for CONCERTA of Older Children With ADHD

Attention Deficit Hyperactivity Disorder

United States
Ortho-McNeil Janssen Scientific Affairs, LLC

Completed

A Complicated Skin and Soft-tissue Infection Patient Registry

Abscess | Cellulitis | Staphylococcal Skin Infections | Surgical Wound Infection | Diabetic Foot Infections
Yale University
Janssen Scientific Affairs, LLC

Not yet recruiting

PET and MRI Imaging With Scopolamine at the Muscarinic M1 Receptor (emo_to2)

Muscarinic Receptor Occupancy

United States
Janssen Scientific Affairs, LLC
Apple Inc.

Active, not recruiting

A Study to Investigate if Early Atrial Fibrillation (AF) Diagnosis Reduces Risk of Events Like Stroke in the Real-World

Atrial Fibrillation

United States
Duke University
Janssen Scientific Affairs, LLC

Completed

The Learning Registry

Atherosclerotic Cardiovascular Disease

United States
Ortho-McNeil Janssen Scientific Affairs, LLC

Completed

CONCERTA Lab School Study

Attention Deficit Hyperactivity Disorder

United States
Ortho-McNeil Janssen Scientific Affairs, LLC

Completed

Study to Evaluate Cycle Control With Norgestimate/Ethinyl Estradiol and Drospirenone/Ethinyl Estradiol in Healthy Sexually Active Females

Contraception
Therapeutic Concepts
Janssen Scientific Affairs, LLC

Unknown

Open Label, Pilot Study of Darunavir Boosted by Cobicistat in Combination With Rilpivirine to Treat HIV+ Naïve Subjects (PREZENT)

HIV Positive

United States
Ortho-McNeil Janssen Scientific Affairs, LLC

Completed

Adult Study / OROS Methylphenidate Hydrochloride (HCL) (OROS MPH) in Adults With Attention Deficit Hyperactivity Disorder (ADHD)

Attention Deficit Disorder With Hyperactivity
Ortho-McNeil Janssen Scientific Affairs, LLC

Terminated

28-30 Month Study Comparing Paliperidone Palmitate With Oral Risperidone for Treating Adults Diagnosed With Schizophrenia Within the Past 5 Years

Schizophrenia

United States, China, Colombia, Bulgaria, India, Malaysia, Russian Federation, Ukraine, Canada, Korea, Republic of, Brazil, Czech Republic
Ortho-McNeil Janssen Scientific Affairs, LLC

Completed

Evaluation of Bacteria in the Mouth and Throat of Healthy Adults Before and After the Administration of Either Levofloxacin or Azithromycin, Both Antibiotic Medications

Healthy Volunteer
University Hospital Southampton NHS Foundation...
Vascular Solutions LLC

Completed

Uterine Fibroid Embolization (UFE) for Symptomatic Fibroids: Comparison of Gel-Bead to Commonly Used Embolic Agents.

Uterine Fibroid | Embolization | Symptoms

United Kingdom
Rockefeller University
Janssen Scientific Affairs, LLC

Withdrawn

Biomarkers in Participants With Hidradenitis Suppurativa Receiving Guselkumab.

Hidradenitis Suppurativa

United States
Ortho-McNeil Janssen Scientific Affairs, LLC

Completed

Study to Measure the Safety of Paliperidone ER (Extended-release) in Patients With Liver Disease

Psychotic Disorders | Schizophrenia | Schizoaffective Disorder

United States
Ortho-McNeil Janssen Scientific Affairs, LLC

Withdrawn

Twelve Month Study Comparing Paliperidone Palmitate and Select Oral Antipsychotics in Adults With Schizophrenia Who Have Been Recently Discharged From an Inpatient Psychiatric Hospital

Schizophrenia
Ortho-McNeil Janssen Scientific Affairs, LLC

Completed

The Effect of Extended-Release Oxybutynin Chloride on Vasomotor Symptoms in Healthy Post-Menopausal Women

Hot Flashes | Menopause
Ortho-McNeil Janssen Scientific Affairs, LLC

Terminated

The Paliperidone ER Observational Study of Economic, Functional, and Clinical Outcomes in Patients With Schizophrenia (POST)

Schizophrenia
Ortho-McNeil Janssen Scientific Affairs, LLC

Completed

Oxycodone User Registry (OUR)

Pain
Paul J. Gagne

Recruiting

Post Market Registry Study of the Philips QuickClear Mechanical Thrombectomy System

Acute Deep Venous Thrombosis of Ileofemoral Vein

United States
Heart Center Research, LLC
Boston Scientific Corporation

Recruiting

Diuretics vs. Afterload Reduction for Treatment of HeartLogic Alerts (DART-HA)

Heart Failure, Congestive

United States
NYU Langone Health
Janssen Scientific Affairs, LLC

Completed

Cognitive Detection of Preclinical AD: Validation Using Biomarkers

Mild Cognitive Impairment

United States
Virginia Commonwealth University
Janssen Scientific Affairs, LLC

Completed

Treatment of Diabetes in Patients With Systolic Heart Failure

Diabetes Mellitus, Type 2 | Heart Failure, Systolic

United States
University of Pennsylvania
Janssen Scientific Affairs, LLC

Completed

Vascular Inflammation in Psoriasis-Ustekinumab (VIP-U) (VIP-U)

Cardiovascular Disease | Psoriasis

United States
University of Pennsylvania
Janssen Scientific Affairs, LLC

Recruiting

Guselkumab vs Golimumab in PsA TNF Inadequate Responder Patients (EVOLUTION)

Psoriatic Arthritis

United States
University of Pennsylvania
Janssen Scientific Affairs, LLC

Not yet recruiting

Guselkumab vs Golimumab in PsA TNF Inadequate Responder Patients (EVOLUTION)

Psoriatic Arthritis

United States
NYU Langone Health
Janssen Scientific Affairs, LLC

Recruiting

Multi-Center PAMPA Study (PAMPA)

Psoriasis

United States, Canada
Thomas Jefferson University
Janssen Scientific Affairs, LLC

Active, not recruiting

Home Based Daratumumab Administration for Patients With Multiple Myeloma

Plasma Cell Myeloma

United States

Clinical Trials Sponsored by Vascular Scientific, LLC

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Congo

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations